Recent progress on nanomedicine-induced ferroptosis for cancer therapy
| Autor: | Yawen Wei, Hajra Zafar, Qi Shen, Faisal Raza, Siyu Ma, Jun Zhang |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Iron Biomedical Engineering Cancer therapy 02 engineering and technology 03 medical and health sciences Neoplasms medicine Ferroptosis Humans General Materials Science Intensive care medicine 030304 developmental biology 0303 health sciences business.industry Cancer 021001 nanoscience & nanotechnology medicine.disease Nanomedicine Innovative Therapies Close relationship Treatment strategy Reactive Oxygen Species 0210 nano-technology business Aggressive malignancies |
| Zdroj: | Biomaterials Science. 9:5092-5115 |
| ISSN: | 2047-4849 2047-4830 |
| DOI: | 10.1039/d1bm00721a |
| Popis: | The current treatment strategies for cancer therapy have posed many problems in achieving high efficacy. Therefore, an urgent step is needed to develop innovative therapies that can win beyond satisfactory results against tumor. Ferroptosis that is a kind of non-apoptotic based programmed cell death has played a crucial role in eradicating tumors by reactive oxygen species and iron-dependent pathways. Research shows a remarkable potential of ferroptosis in eliminating aggressive malignancies resistant to traditional therapies. The combination of nanomedicine and ferroptosis has revealed a close relationship for the treatment of various cancer types with high efficacy. This review introduces the basics of nanomedicine-based ferroptosis first to emphasize the feasibility and properties of ferroptosis in cancer therapy. Then, the current research on the applications of nanomedicine for the ferroptosis-based anticancer therapy is highlighted. Finally, conclusions and future research directions in perspective of various challenges in developing nanomedicine-based ferroptosis into clinical therapeutics are discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|